Florida’s new stem cell law opened a narrow pathway, not a regulatory free pass. Patients still need to distinguish state authorization from federal FDA approval before choosing a clinic.
Schedule a consultation with Miami Stem Cell to get clear answers about stem cell therapy in Florida.
Is stem cell therapy legal in Florida? Yes, but legality depends on the treatment, medical purpose, physician, product source, required disclosures, and federal rules. SB 1768 allows licensed Florida physicians to provide certain therapies for orthopedic conditions, wound care, and pain management when strict state requirements are met. It does not erase FDA authority or make every stem cell product FDA-approved. Before treatment, patients should receive signed informed consent that explains the product’s FDA status, possible risks and benefits, and investigational status in plain language. A safety-focused clinic should also verify accredited sourcing, documented cGMP-compliant processing, physician oversight, clear documentation, careful patient screening, and plans for follow-up and adverse-event reporting.
The next section, “Is stem cell therapy legal in Florida?”, explains the law’s narrow scope and why state permission is not the same as FDA approval. It also shows which disclosures and clinic standards deserve your attention before you consent to care. Here’s how.
Is stem cell therapy legal in Florida?
Yes, certain stem cell therapies are legal under Florida’s state framework when a licensed Florida physician follows its limits and safety rules. The answer to “is stem cell therapy legal in Florida” still depends on the proposed use, product, provider, and required disclosures. State permission does not remove federal oversight or mean every therapy has FDA approval.
Florida’s state pathway
Florida Senate Bill 1768 took effect on July 1, 2025. It created a state pathway for certain stem cell therapies used in orthopedic care, wound care, and pain management. The law does not give broad permission for every condition or type of treatment. Patients can review the Florida SB 1768 stem cell guidance for orthopedic care in more detail.
Under this framework, a licensed physician may provide a qualifying therapy that lacks FDA approval if strict state rules are met. The physician must clearly disclose that status and obtain written informed consent. That consent should explain the treatment’s investigational status, possible risks, and possible benefits before care begins.
State permission and federal oversight
Florida law does not override federal law. A treatment may fit Florida’s pathway while still facing separate federal requirements based on how its biological product is made and used. The FDA’s consumer alert on regenerative medicine products explains that many marketed stem cell products are not FDA-approved.
For patients, this distinction matters. “Legal under a Florida pathway” and “FDA-approved” are not equal claims. A clinic should explain both the state basis for care and the product’s federal status. Patients can also read about FDA-approved stem cell treatment guidance before discussing a proposed treatment.
What patients should verify
Before moving forward, ask which Florida-authorized use applies to your case. Request the treatment’s FDA status, tissue source, processing details, and provider credentials in writing. A careful review should also cover your health history, current medicines, allergies, possible contraindications, and any needed imaging.
- Confirm that a licensed Florida physician will provide and oversee the treatment.
- Ask why the proposed use fits Florida’s allowed scope.
- Read the full consent form and ask about risks, benefits, and other care options.
- Verify whether the product is FDA-approved, investigational, or subject to another federal pathway.
A consultation should focus on whether the proposed care fits both the patient’s needs and the relevant rules. Clear answers do not promise a result. They show how the provider approaches safety, consent, and compliance before treatment.
What Florida SB 1768 changed for patients
Florida Senate Bill 1768 took effect on July 1, 2025. It created a state pathway for certain stem cell therapies that do not have FDA approval. For patients asking whether stem cell therapy is legal in Florida, the key answer is simple. Legality depends on the physician, intended use, disclosures, and federal rules.
A limited state pathway
SB 1768 did not make every stem cell treatment legal for every condition. It allows licensed Florida physicians to administer certain therapies for orthopedic conditions, wound care, and pain management. The law does not authorize their use for autism, anti-aging, or systemic conditions.
This narrower scope matters when patients compare clinics and proposed care plans. A provider should be able to explain how the intended treatment fits within the law. Patients can also review the Florida stem cell law update for orthopedic care before a consultation.
State and federal rules
Florida’s pathway does not replace federal oversight. SB 1768 states that it does not preempt federal law, so state and federal requirements still apply together. Permission under Florida law does not automatically mean that the FDA has approved a product or procedure.
The FDA advises patients to ask whether a regenerative medicine product is approved or studied under an active application. This dual system makes precise wording important. State permission and FDA approval are separate questions.
Patients should first ask whether a Florida physician may offer the therapy. They should then ask whether the intended use fits state law. Finally, they should confirm the product’s federal status.
- Ask whether the treating physician holds an active Florida license.
- Ask which permitted use applies to the proposed therapy.
- Ask the clinic to explain the product’s federal regenerative medicine rules in clear terms.
Disclosures patients should expect
When a covered treatment is not FDA-approved, the Florida framework requires a clear disclosure of that fact. Patients should also receive written informed consent that notes the treatment’s investigational status. The consent should describe potential risks and benefits before the patient agrees to proceed.
These disclosures are not minor paperwork. They help patients understand what is known, what remains uncertain, and which rules apply. A careful discussion should leave enough time for questions about the product source, proposed use, expected follow-up, and other care options.
SB 1768 changed access, but it did not remove the need for careful screening. A pre-treatment review may cover medical history, current medicines, allergies, possible contraindications, and relevant imaging. Patients should expect the physician to assess whether the proposed care suits their health needs and fits the permitted use.
The practical change is a regulated Florida pathway with clear limits, not broad approval of all stem cell therapies. Patients can use those limits to ask better questions and compare a clinic’s claims with its consent documents.
Which conditions fall within Florida stem cell therapy law?
Florida’s state pathway does not cover every condition that a patient may want to address. It limits physician-administered stem cell therapy to orthopedic conditions, wound care, and pain management. These categories help answer whether stem cell therapy is legal in Florida for a specific use. They do not mean that each person or procedure is automatically eligible.
Three condition categories
Orthopedic conditions involve the body’s joints, bones, muscles, tendons, and other structures that support movement. A licensed physician must still decide whether a proposed therapy fits the law and the patient’s needs. Readers exploring orthopedic care can review the clinic’s guide to the orthopedic stem cell law details in Florida.
Wound care is another category named in the state framework. Pain management is the third. Pain may relate to an orthopedic issue, but the legal category alone does not establish its cause. A careful assessment should connect the patient’s symptoms, diagnosis, and treatment goal before a physician recommends care.
- Orthopedic conditions: concerns involving structures that support movement, subject to a physician’s clinical review.
- Wound care: care aimed at a wound, with the treatment plan based on the person’s health and wound status.
- Pain management: care focused on pain, after a physician assesses its source and the patient’s wider health needs.
Limits of the state pathway
The Florida framework is narrow. According to the customer knowledge base, it does not authorize treatment for autism, anti-aging, or systemic conditions. A clinic should not treat the three permitted categories as an open path for unrelated uses. The planned use must stay within the state-law scope.
State authorization also does not settle the separate question of federal status. Patients should ask whether a proposed product or use has FDA approval and what disclosures apply. The clinic’s guide to FDA stem cell therapy guidance explains why that distinction matters. Clear consent should describe investigational status, possible risks, and possible benefits before treatment.
Why candidacy remains individual
Two people with similar pain can have different causes, health risks, and treatment goals. That is why category fit is only the first screen. A physician may review medical history, current medicines, allergies, possible reasons to avoid treatment, and relevant imaging. This review helps determine whether the proposed approach is suitable and lawful for that person.
Patients should expect a consultation, not a promise based on a diagnosis label. The physician should explain the proposed product, intended use, available options, and uncertainties in plain language. If the condition falls outside orthopedic care, wound care, or pain management, the state pathway described here does not authorize it.
Why FDA status still matters in Florida
Federal and state authority
When patients ask, “is stem cell therapy legal in Florida,” the answer involves both state and federal rules. Florida may define when licensed physicians can provide certain therapies within the state. Yet state permission does not replace federal oversight of drugs and biological products.
This distinction matters because “legal in Florida” and “FDA-approved” do not mean the same thing. A treatment may fit a state pathway while lacking FDA approval for its proposed use. Florida’s framework also requires clear disclosure when a treatment is not FDA-approved. Patients can review the state’s state stem cell therapy pathway before discussing a procedure.
FDA status tells patients which federal review path applies and what evidence regulators have assessed. It does not predict how every patient will respond. The FDA’s patient information on regenerative medicine therapies warns that unapproved products may carry safety risks. It also advises patients to ask whether an investigational product is being studied under an FDA-authorized application.
Sections 351 and 361
Sections 351 and 361 describe different federal routes for certain human cell and tissue products. A product regulated under Section 351 generally follows a drug and biologic approval route. That route can include an Investigational New Drug application, clinical trials, and a Biologics License Application.
Some products may qualify for regulation under Section 361 if they meet a narrow set of federal criteria. Those criteria concern factors such as how tissue is processed and used. Calling a product “361 compliant” is not the same as saying the FDA approved it. Patients should ask the clinic to explain the product category and its basis in plain language.
The difference can seem technical, but it shapes what a clinic should disclose. It also helps patients judge claims about safety, approval, and expected benefits. This guide to stem cell FDA status overview gives added context on what approval means in regenerative medicine.
Questions patients should ask
A trustworthy consent process should state whether the proposed treatment is FDA-approved for the planned use. If it is investigational, the consent form should say so. It should also explain known risks, possible benefits, alternatives, product sourcing, and the limits of current evidence.
Be cautious when a clinic uses phrases such as “FDA registered,” “FDA compliant,” or “made in an FDA-registered facility” as proof of approval. Those phrases may describe a facility or process, not approval of the treatment itself. Ask for the exact approval, authorization, or regulatory basis behind each claim.
Patients should also ask who processes the product, where it comes from, and what testing supports its use. Request time to read the consent form before making a decision. Clear answers do not guarantee an outcome, but they make it easier to compare options and spot misleading claims.
What disclosures should Florida stem cell patients expect?
A clear disclosure should help you understand the proposed treatment before you decide. It should explain what the therapy is, why a physician recommends it, and what remains uncertain. This discussion matters when asking is stem cell therapy legal in Florida, because state permission does not replace federal rules.
FDA status and informed consent
Florida’s framework calls for written informed consent that states when a treatment is not FDA-approved. The consent should also identify its investigational status and explain potential risks and benefits. The FDA’s regenerative medicine guidance also urges patients to ask whether a product is approved for its proposed use.
Read the consent form before signing it, and ask for plain answers to unfamiliar terms. A careful physician should explain the biological product, its source, how it is processed, and how it will be given. The discussion should also cover follow-up care and steps to take if a side effect occurs.
Costs, alternatives, and realistic outcomes
Patients should receive a clear cost estimate before treatment. Ask what the quoted fee includes, whether follow-up visits cost extra, and whether any part may be refundable. Price transparency helps you compare the proposed care with other reasonable options and plan for the full expense.
The consent discussion should cover alternatives, including waiting, physical therapy, medication, injections, or surgery when relevant. It should explain possible benefits without promising a result. No responsible clinic can guarantee pain relief, tissue repair, or a set recovery time.
You should also know what happens if you change your mind before the procedure. Ask whether canceling affects your deposit and which services have already been provided. Written answers can prevent confusion later.
Questions to ask before agreeing
Before making a choice, ask the physician why the treatment fits your diagnosis and medical history. You should also ask what evidence supports that use and which risks apply to you. The clinic should give you time to consider the answers without pressure.
- Is this treatment FDA-approved, or is it investigational?
- What risks, benefits, and alternatives apply to my case?
- What does the full price include?
- What follow-up plan will I receive?
- Who should I contact if I have a concern?
Florida’s state pathway applies only to certain uses and does not override federal law. Review the Florida patient access update for orthopedic care before comparing options. To discuss disclosures for your needs, contact Miami Stem Cell for a personalized consultation.
How to evaluate a Florida stem cell clinic’s safety standards
Asking whether stem cell therapy is legal in Florida is only the first step. A legal pathway does not prove that every clinic, product, or procedure is safe. Patients should also review the treating physician, tissue source, processing controls, consent documents, and follow-up plan.
Ask the clinic to explain the treatment’s regenerative medicine approval basics in plain language. The FDA also advises patients to confirm whether a regenerative medicine product is approved or being studied under an active application. Its patient guidance on regenerative medicine therapies explains key questions to ask before treatment.
Core safety standards to verify
A responsible clinic should provide records, not just verbal assurances. Request the physician’s full name and Florida license number, then verify that the license is active. Ask which doctor will perform the procedure and who will handle complications after treatment.
| Safety check. | What to ask. | Why it matters. |
|---|---|---|
| Physician license. | Ask who oversees care. | Shows medical accountability. |
| Tissue source. | Ask for donor records. | Supports traceable sourcing. |
| Accreditation. | Ask about AATB or similar review. | Shows outside quality checks. |
| Processing controls. | Ask about cGMP and clean rooms. | Helps reduce contamination risk. |
Accreditation and manufacturing controls answer different questions. AATB, AABB, NMDP, or WMDA records can support review of tissue or donor practices. cGMP records. Clean-room standards, and validated processes address how a product is made and handled.
Documents and screening questions
For umbilical cord tissue, ask whether it came from a healthy, full-term birth with maternal consent. The clinic should also confirm that no fetal or embryonic tissue was used. Traceability should connect the donor source, processing facility, product lot, and certificate of analysis.
Before recommending care, the physician should review your health history, current medicines, allergies, and possible contraindications. Testing or imaging may be needed based on the condition. A safe screening process may also find that treatment is not a good fit.
- Who collected, processed, tested, stored, and shipped the product?
- Can the clinic provide a lot-specific certificate of analysis before treatment?
- What do the sterility, identity, and other test results show?
- What risks, limits, and alternatives appear in the consent form?
- Who should the patient call if a problem occurs after the procedure?
Consent and follow-up
Read the full consent form before paying or scheduling. It should state whether the treatment is investigational and explain known risks, possible benefits, and alternatives. It should not promise a cure or guaranteed result.
Follow-up should be planned before treatment, not offered only when symptoms appear. Ask when the clinic will check progress and how it records side effects. Patients comparing local options can also review Florida’s legal status of stem cell therapy before discussing a personal care plan.
How Miami Stem Cell approaches compliant patient care
Miami Stem Cell treats compliance as part of patient care, not as a form completed after a treatment choice. The clinic starts with a personal review, explains key limits, and avoids promising a certain result.
This approach matters because the answer to “is stem cell therapy legal in Florida” depends on the treatment, purpose, provider, and applicable rules. State permission does not remove federal oversight or the need for clear patient disclosures.
A personal review before treatment
A consultation begins with the patient’s goals, health history, current medicines, allergies, and possible reasons to avoid treatment. The care team may also review imaging or other tests when they are useful for a safe plan.
That review helps the clinician decide whether a person may be a suitable candidate for stem cell therapy or another option. A plan for joint pain or pain management should fit the diagnosis and the patient’s health, rather than follow a standard package.
- Review the diagnosis, symptoms, and treatment goals.
- Screen for medicines, allergies, and health risks.
- Discuss reasonable options, limits, and possible next steps.
Ethical sourcing and safety standards
Miami Stem Cell reports using umbilical cord tissue from healthy, full-term births with maternal consent. Its stated sourcing standards exclude fetal and embryonic tissue. The clinic also considers tissue-bank credentials, processing controls, and product records when reviewing biologic materials.
Patients should know where a product comes from, how it was handled, and what oversight applies. The FDA’s regenerative medicine guidance for patients also urges people to ask whether a product is FDA-approved or used under an FDA-authorized clinical trial.
These questions support a safer, more informed choice. They also help patients separate documented standards from broad marketing claims.
Clear consent without guaranteed outcomes
Transparent care includes a direct talk about a proposed product’s regulatory status, possible risks, possible benefits, and other choices. Written consent should state when a treatment is investigational or is not FDA-approved for the proposed use.
Miami Stem Cell reports performing more than 8,000 procedures, but procedure volume cannot guarantee an outcome for any patient. Responses can differ based on the condition, health history, treatment plan, and other factors.
A patient can use the consultation to ask detailed questions and decide whether the proposed plan fits their needs. To discuss candidacy, records, and compliance questions, patients can schedule a personal consultation with the Miami clinic.
Frequently Asked Questions
What conditions can be treated with stem cell therapy under Florida law?
Florida SB 1768 creates a state pathway for licensed physicians to provide qualifying stem cell therapies related to orthopedics, wound care, and pain management. The law does not authorize every proposed use, including autism, anti-aging, or systemic conditions. A physician must also determine whether a therapy falls within the physician’s professional scope and meets applicable state and federal requirements.
Does Florida law allow non-FDA-approved stem cell treatments?
Yes, Florida law permits licensed physicians to administer certain qualifying therapies that are not FDA-approved for orthopedics, wound care, or pain management. However, Florida law does not replace or override federal authority. Patients should review a treatment’s FDA regulatory status, its intended use, and all required disclosures before deciding whether to proceed.
What disclosures must a Florida stem cell clinic provide?
A clinic offering a qualifying therapy that is not FDA-approved must clearly disclose that status. The physician must obtain written informed consent that explains the therapy’s investigational nature, potential risks and benefits, available alternatives, and costs. Patients should receive enough time to review the information, ask questions, and understand that outcomes are not guaranteed before signing.
What are the facility and sourcing requirements for stem cell therapy in Florida?
Qualifying products must come from ethically obtained perinatal or adult tissue, not fetal or embryonic tissue. Florida’s framework also calls for recognized tissue-bank or donor-program certification and appropriate manufacturing controls. Patients can ask for the supplier’s accreditation, FDA facility registration, current good manufacturing practice information, donor screening standards, and a product-specific Certificate of Analysis.
How can patients check whether a Florida stem cell clinic follows safety standards?
Patients can confirm that the treating clinician holds an active Florida medical license and ask which condition the therapy addresses. A safety-focused clinic should explain product sourcing, laboratory accreditation, manufacturing controls, sterility testing, and adverse-event procedures. It should also perform a medical evaluation, review medications and allergies, screen for contraindications, and provide signed informed consent before treatment.
Schedule a consultation with Miami Stem Cell
If you are asking whether stem cell therapy is legal in Florida, the safest next step is a medical consultation. Miami Stem Cell can explain your options, the legal limits, and the disclosures you should receive before care. Our team focuses on transparent, safety-first regenerative medicine guidance for patients in Miami and throughout Florida.
Schedule a consultation with Miami Stem Cell to discuss your goals and learn whether a compliant regenerative medicine plan may be appropriate for you.
